• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺炎链球菌菌株的血清型分布及抗生素敏感性:13价肺炎球菌结合疫苗接种后五年监测结果

Serotypes distribution and antibiotic susceptibility of Streptococcus pneumoniae strains: five-year surveillance results of post-PCV-13.

作者信息

Atıcı Serkan, Güneşer Deniz, Kepenekli Eda, Söyletir Güner, Soysal Ahmet

机构信息

Department of Pediatrics, Division of Pediatric Infectious Disease, Okan University School of Medicine, Aydınlı Yolu Cd. No:2, Tuzla/Istanbul, 34947, Turkey.

Department of Microbiology, Marmara University School of Medicine, Istanbul, Turkey.

出版信息

BMC Pediatr. 2025 Mar 28;25(1):244. doi: 10.1186/s12887-025-05593-w.

DOI:10.1186/s12887-025-05593-w
PMID:40155854
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11951652/
Abstract

BACKGROUND

Approximately 100 capsular serotypes of S. pneumonia have been identified according to the composition of their capsular polysaccharides, currently available vaccines do not cover many of these. Pneumococcal vaccination serotype coverage is essential for preventing noninvasive and invasive illnesses as well as asymptomatic carriage. We aimed to determine the serotype distribution and antimicrobial susceptibility pattern of pneumococcal clinical isolates in this study. We also analyzed the serotype coverage rates of PCV13, which is applied in the NIP, and PCV-15 and PCV20, which have been introduced recently.

METHODS

This study is a retrospective surveillance of pneumococcal infections including invasive pneumococcal isolates (IPIs) and non-invasive pneumococcal isolates (non-IPIs).

RESULTS

A total of 420 isolates from 356 different patients aged 0-89 years were enrolled in the study. A total of 420 pneumococcal isolates were serotyped and 26 different serotypes were detected. Serotype 19 F was the most prevalent serotype (n = 96, 22.8%), followed by 6 A/B (n = 55, 13.1%), 23 F (n = 49, 11.6%), 3 (n = 22, 5.2%) and 19 A (n = 16, 3.8%).

CONCLUSIONS

Surveillance studies of pneumococcal diseases are critical to investigating current serotype distributions, antibiotic resistance status, and frequency of IPD cases. Considering the increasing antibiotic resistance rates of S. pneumoniae, it is necessary to provide protective immunization by switching to more comprehensive PCV vaccines rather than treatment.

CLINICAL TRIAL NUMBER

Not applicable.

摘要

背景

根据肺炎链球菌荚膜多糖的组成,已鉴定出约100种荚膜血清型,目前可用的疫苗并未涵盖其中许多血清型。肺炎球菌疫苗血清型覆盖率对于预防非侵袭性和侵袭性疾病以及无症状携带至关重要。在本研究中,我们旨在确定肺炎球菌临床分离株的血清型分布和抗菌药敏模式。我们还分析了国家免疫规划中应用的13价肺炎球菌结合疫苗(PCV13)以及最近引入的15价肺炎球菌结合疫苗(PCV-15)和20价肺炎球菌结合疫苗(PCV20)的血清型覆盖率。

方法

本研究是一项对肺炎球菌感染的回顾性监测,包括侵袭性肺炎球菌分离株(IPIs)和非侵袭性肺炎球菌分离株(非IPIs)。

结果

本研究共纳入了来自356名年龄在0至89岁不同患者的420株分离株。共对420株肺炎球菌分离株进行了血清分型,检测到26种不同的血清型。19F血清型是最常见的血清型(n = 96,22.8%),其次是6A/B(n = 55,13.1%)、23F(n = 49,11.6%)、3(n = 22,5.2%)和19A(n = 16,3.8%)。

结论

肺炎球菌疾病的监测研究对于调查当前血清型分布、抗生素耐药状况和侵袭性肺炎球菌病(IPD)病例频率至关重要。考虑到肺炎链球菌抗生素耐药率不断上升,有必要通过改用更全面的肺炎球菌结合疫苗来提供保护性免疫,而不是进行治疗。

临床试验编号

不适用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c656/11951652/b974bf92b1a8/12887_2025_5593_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c656/11951652/b974bf92b1a8/12887_2025_5593_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c656/11951652/b974bf92b1a8/12887_2025_5593_Fig1_HTML.jpg

相似文献

1
Serotypes distribution and antibiotic susceptibility of Streptococcus pneumoniae strains: five-year surveillance results of post-PCV-13.肺炎链球菌菌株的血清型分布及抗生素敏感性:13价肺炎球菌结合疫苗接种后五年监测结果
BMC Pediatr. 2025 Mar 28;25(1):244. doi: 10.1186/s12887-025-05593-w.
2
serotypes and factors associated with antimicrobial resistance in Invasive pneumococcal disease cases in Latvia, 2012-2022.2012 - 2022年拉脱维亚侵袭性肺炎球菌病病例中与抗菌药物耐药性相关的血清型和因素
Front Public Health. 2025 Mar 12;13:1501821. doi: 10.3389/fpubh.2025.1501821. eCollection 2025.
3
Non-invasive infections are associated with different serotypes than invasive infections, Belgium, 2020 to 2023.2020 年至 2023 年期间,与非侵入性感染相关的血清型与侵入性感染不同。
Euro Surveill. 2024 Nov;29(45). doi: 10.2807/1560-7917.ES.2024.29.45.2400108.
4
Serotype distribution of invasive Pneumococcal disease in a tertiary children's hospital in Vietnam.越南一家三级儿童医院侵袭性肺炎球菌疾病的血清型分布
BMC Infect Dis. 2025 Mar 26;25(1):412. doi: 10.1186/s12879-025-10672-5.
5
Population genetic structure, serotype distribution and antibiotic resistance of causing invasive disease in children in Argentina.引起阿根廷儿童侵袭性疾病的种群遗传结构、血清型分布和抗生素耐药性。
Microb Genom. 2021 Sep;7(9). doi: 10.1099/mgen.0.000636.
6
Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon.黎巴嫩全国性监测研究中侵袭性肺炎链球菌分离株的流行病学特征、血清型和抗菌药物敏感性。
Vaccine. 2012 Dec 31;30 Suppl 6:G11-7. doi: 10.1016/j.vaccine.2012.07.020.
7
Nationwide population-based surveillance of invasive pneumococcal disease in children in Japan (2014-2022): Impact of 13-valent pneumococcal conjugate vaccine and COVID-19 pandemic.日本儿童侵袭性肺炎球菌疾病的全国性人群监测(2014 - 2022年):13价肺炎球菌结合疫苗和新冠疫情的影响
Vaccine. 2025 Apr 30;54:127138. doi: 10.1016/j.vaccine.2025.127138. Epub 2025 Apr 18.
8
Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae associated with invasive pneumococcal disease among adults in Japan.日本成人侵袭性肺炎球菌病相关肺炎链球菌血清型分布及抗菌药物敏感性。
Int J Infect Dis. 2021 Jan;102:260-268. doi: 10.1016/j.ijid.2020.10.017. Epub 2020 Oct 13.
9
Vaccine-driven serotype-rearrangement is seen with latency in clinical isolates: Comparison of carried and clinical pneumococcal isolates from the same time period in Hungary.疫苗驱动的血清型重排具有潜伏期,在临床分离株中可见:来自同一时期匈牙利的携带株和临床分离株的比较。
Vaccine. 2019 Jan 3;37(1):99-108. doi: 10.1016/j.vaccine.2018.11.026. Epub 2018 Nov 22.
10
Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolates from 17 Chinese cities from 2011 to 2016.2011 年至 2016 年中国 17 个城市肺炎链球菌分离株的血清型分布和抗生素耐药性。
BMC Infect Dis. 2017 Dec 29;17(1):804. doi: 10.1186/s12879-017-2880-0.

本文引用的文献

1
An economic evaluation of pneumococcal conjugate vaccines, PCV20 versus PCV15, for the prevention of pneumococcal disease in the Swedish pediatric population.对肺炎球菌结合疫苗PCV20与PCV15在瑞典儿科人群中预防肺炎球菌疾病的经济学评估。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2400751. doi: 10.1080/21645515.2024.2400751. Epub 2024 Sep 15.
2
The potential impact of PCV-13, PCV-15 and PCV-20 vaccines in Colombia.13价肺炎球菌结合疫苗、15价肺炎球菌结合疫苗和20价肺炎球菌结合疫苗在哥伦比亚的潜在影响。
Vaccine. 2024 Mar 7;42(7):1435-1439. doi: 10.1016/j.vaccine.2024.01.086. Epub 2024 Feb 9.
3
Vaccination to Reduce Antimicrobial Resistance Burden-Data Gaps and Future Research.
接种疫苗以减轻抗菌药物耐药性负担——数据差距和未来研究。
Clin Infect Dis. 2023 Dec 20;77(Suppl 7):S597-S607. doi: 10.1093/cid/ciad562.
4
Serotype distribution of and pneumococcal vaccine coverage in adults in Turkey between 2015 and 2018.2015 年至 2018 年土耳其成人中 型和肺炎球菌疫苗接种率的血清型分布。
Ann Med. 2023 Dec;55(1):266-275. doi: 10.1080/07853890.2022.2160877.
5
A New Pneumococcal Capsule Type, 10D, is the 100th Serotype and Has a Large Fragment from an Oral Streptococcus.一种新型肺炎球菌荚膜类型 10D 是第 100 种血清型,具有来自口腔链球菌的大片段。
mBio. 2020 May 19;11(3):e00937-20. doi: 10.1128/mBio.00937-20.
6
Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults.20 价肺炎球菌结合疫苗在健康成年人中的 1 期临床试验。
Vaccine. 2019 Sep 30;37(42):6201-6207. doi: 10.1016/j.vaccine.2019.08.048. Epub 2019 Sep 5.
7
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants.15 价肺炎球菌结合疫苗(PCV15)在健康婴儿中的安全性和免疫原性。
Vaccine. 2018 Oct 29;36(45):6883-6891. doi: 10.1016/j.vaccine.2018.02.113. Epub 2018 Sep 21.
8
The impact of a pneumococcal conjugate vaccination program on the nasopharyngeal carriage, serotype distribution and antimicrobial resistance of Streptococcus pneumoniae among healthy children in Turkey.肺炎球菌结合疫苗接种计划对土耳其健康儿童鼻咽部肺炎链球菌携带情况、血清型分布及抗菌药物耐药性的影响。
Vaccine. 2016 Jul 19;34(33):3894-900. doi: 10.1016/j.vaccine.2016.05.043. Epub 2016 Jun 11.
9
Measuring the effects of pneumococcal conjugate vaccine (PCV7) on Streptococcus pneumoniae carriage and antibiotic resistance: the Palestinian-Israeli Collaborative Research (PICR).评估肺炎球菌结合疫苗(PCV7)对肺炎链球菌携带及抗生素耐药性的影响:巴勒斯坦-以色列合作研究(PICR)
Vaccine. 2015 Feb 18;33(8):1021-6. doi: 10.1016/j.vaccine.2015.01.003. Epub 2015 Jan 12.
10
Increase in the nasopharyngeal carriage of non-vaccine serogroup 15 Streptococcus pneumoniae after introduction of children pneumococcal conjugate vaccination in Hong Kong.在香港引入儿童肺炎球菌结合疫苗后,非疫苗血清型15肺炎链球菌的鼻咽部携带率上升。
Diagn Microbiol Infect Dis. 2015 Feb;81(2):145-8. doi: 10.1016/j.diagmicrobio.2014.11.006. Epub 2014 Nov 20.